Publication Support for
SCI, SCOPUS & PubMed
Journals
End-to-end support from journal selection to acceptance — journal matching, submission assistance, abstract & graphical abstracts, reviewer-response strategy, and rejection recovery. Human experts, ICMJE & COPE compliant.
Getting accepted is a process, not a single step
A strong manuscript still gets desk-rejected when it lands in the wrong journal, misses a submission requirement, or arrives without the cover materials editors expect. Publication support manages everything that sits between a finished draft and an acceptance letter.
Editverse handles scientific journal selection matched to scope and indexing, full submission-system assistance, abstract and graphical-abstract preparation, referee recommendations, reviewer-response strategy, and structured rejection analysis when a paper needs a second route to publication.
Every recommendation is grounded in the target journal's actual scope, indexing status, and author guidelines — not generic advice. Work is handled by people, documented, and aligned with ICMJE and COPE standards.
- ICMJE authorship — guidance keeps you as the accountable author; we never ghost-author.
- COPE-aligned handling of submissions, disclosures, and reviewer communication.
- No predatory journals — recommendations are screened for indexing and legitimacy.
- Signed NDA and confidential handling of unpublished work.
Compare Platinum, Gold & Silver
Three bundled tiers covering everything from editing through acceptance. Pick a complete package, or build your own from the individual services above.
| Editing level | Substantive Editing | Substantive Editing | Copyediting |
| Pre-Submission Peer Review | |||
| Artwork Preparation | |||
| Plagiarism Correction [<5%] | |||
| Journal Selection | |||
| Target Journal Formatting | |||
| Abstract Word Count Reduction | |||
| Cover Letter Writing | |||
| Journal Submission | |||
| Response to the Reviewers [Editing] | |||
| Revised Manuscript Submission | |||
| Support window | Support till manuscript is accepted | 240 days support | 180 days support |
All tiers include: journal selection, target-journal formatting, journal submission and revised-manuscript submission. Prices are live and link to checkout · ICMJE & COPE compliant · signed NDA.
We screen every journal so your work doesn't disappear
Predatory journals take your fee, skip real peer review, and publish in venues that funders, promotion committees and indexing databases don't recognise. A paper there can be worse than unpublished — and is hard to withdraw and re-submit elsewhere.
Before we ever recommend a journal, we verify it. Every target is checked against recognised indexing and integrity sources, and screened for the warning signs predatory publishers share.
The only legitimate Impact Factor comes from Clarivate's Journal Citation Reports. Metrics like "Global Impact Factor", "SJIF" or "CiteFactor" are sold to journals and mean nothing — we treat them as a warning sign, not a credential.
What we verify before recommending a journal
No single list is perfect, so we cross-check several. A journal's current indexing status always overrides historical or self-reported claims.
Human-verified work, with an AI fabrication shield
AI can invent citations, misattribute findings, and smuggle fabricated data into otherwise solid work — and journals increasingly screen for it. We use AI only as a checked assistant, never as an unverified author, and every reference and claim is confirmed against its real source before your paper goes near a submission portal. You stay the accountable author throughout.
- Hallucinated citations — references that don't exist or don't support the claim.
- Fabricated or altered data slipping into results unnoticed.
- Undisclosed AI authorship that breaches journal and ICMJE policy.
- AI-detector flags that make reviewers question the whole submission.
Supporting researchers across 80+ countries
From a single journal-selection request to a full submission engagement — we've worked with authors from clinical medicine to engineering, across every major indexing database and publisher.
We match and submit to journals published by every major academic publisher — across all major indexing databases. A representative selection:
24 of 80+ countries shown. Support available in English for researchers worldwide.
Pick the right level of support for your situation
Not every paper needs the same help. These three questions narrow it down quickly.
A factual comparison based on published service descriptions. Competitor names are partially masked.
| Feature | Editverse | En**o | Ed**age | Wo**voice |
|---|---|---|---|---|
| Predatory journal screening | ✓ DOAJ · COPE · Think.Check.Submit | Partial | ✗ | ✗ |
| AI fabrication check | ✓ Reference + claim verification | ✗ | ✗ | ✗ |
| ICMJE authorship compliance | ✓ Documented throughout | Stated | Stated | ✗ |
| COPE-aligned handling | ✓ Full | Partial | Partial | ✗ |
| Rejection analysis & re-route | ✓ Structured, journal-specific | ✗ | Basic | ✗ |
| Reviewer-response support | ✓ Included in Gold & Platinum | ✓ | Add-on | ✗ |
| Graphical abstract | ✓ $150 standalone or bundled | Add-on | Add-on | ✗ |
| Transparent fixed pricing | ✓ Live prices, direct checkout | Quote-based | Quote-based | Quote-based |
| Support until accepted | ✓ Platinum tier | ✗ | ✗ | ✗ |
| Signed NDA | ✓ Every engagement | On request | On request | ✗ |
Comparison based on publicly available service descriptions as of 2026. ✓ = included as standard · Partial/Add-on = available with limitations or extra cost · ✗ = not offered or not stated.
Publication support, priced transparently
Every service below is a real, orderable engagement with a fixed price — choose a complete package or a single service to fill a specific gap.
All prices shown are live and link directly to checkout. ICMJE & COPE compliant · signed NDA on every engagement.
Full Publication Packages
End-to-end bundles that take a finished manuscript all the way to submission.
Journal Selection & Submission
Find the right journal and get through the submission system cleanly.
Abstracts & Visual Assets
The pieces editors and readers see first.
Author Profile & References
Set up your scholarly identity and citations correctly.
Who stands behind this work
Editverse is a trading name of Neucite LLC, operating since 2019. Every engagement is documented, ethics-compliant and traceable to a named specialist.
- Subject-matter specialists with active publication records in their respective fields handle each engagement — not generalist editors assigned by volume.
- Every citation and claim is verified against its source before work leaves our team — PubMed and CrossRef confirmed, no AI-hallucinated references.
- Signed NDA on every engagement — your unpublished data and manuscripts are handled in confidence and never repurposed.
- You remain the accountable author throughout — we never ghost-author, co-author or take credit for your intellectual contribution.
- Transparent pricing — every service has a live, fixed price on this page. No bait-and-switch quotes after scoping.
What separates our publication support
Plenty of services will format a paper and click submit. Few treat the path to acceptance as a strategy. Here is where our approach is different.
Journal fit, not journal wishlists
We match your paper to journals by scope, indexing, scope-of-readership and realistic acceptance odds — not the highest impact factor you hope for. Better-targeted submissions mean fewer desk rejections.
Scope-based matchingIndexed journals only
Every recommendation is screened against SCI/SCIE, Scopus and PubMed indexing and checked for predatory-journal signals — so your work lands somewhere that counts toward your record.
No predatory venuesICMJE & COPE compliant
Authorship, disclosures, reviewer suggestions and submission declarations follow ICMJE and COPE standards. You stay the accountable author throughout — we never ghost-author.
Ethics-firstRejection is a route, not a dead end
A rejection comes with structured analysis of why — and a concrete plan for the next journal. Many papers we support are accepted on their second targeted submission.
Recovery built inHandled by people, documented
Real subject-aware specialists do the work, and every recommendation is documented so you understand the reasoning — not a black box, not auto-generated journal lists.
Human + transparentSupport until accepted
Package support continues through revisions and reviewer rounds until the manuscript is accepted — not a one-off deliverable that ends at submission.
End-to-endMore ways Editverse supports your research
Your manuscript is ready.
Let's get it published.
Choose a package for end-to-end support, or pick a single service for the specific gap you need to fill. Fixed prices, signed NDA, ICMJE & COPE compliant — support until accepted.
Frequently asked questions
Editverse publication support covers the full journey from finished manuscript to accepted paper: scientific journal selection matched to scope and indexing, manuscript editing, target-journal formatting, plagiarism correction, abstract and graphical-abstract preparation, cover letter writing, journal submission assistance, point-by-point response to reviewers, and rejection analysis with a re-submission plan. The Platinum package includes all of these with support until acceptance; Gold and Silver cover progressively focused subsets.
Editverse maintains a 97.3% acceptance rate across manuscripts we support for SCI/SCIE (Web of Science), Scopus and PubMed-indexed journals. This reflects completed engagements where a manuscript went through our full preparation and submission workflow.
The Platinum package ($625) is our most comprehensive — it includes substantive editing, pre-submission peer review, artwork preparation, plagiarism correction, journal selection, formatting, abstract reduction, cover letter, submission, reviewer response and support until the manuscript is accepted. The Gold package ($500) covers substantive editing, artwork, plagiarism correction, journal selection, formatting, abstract reduction, submission, reviewer response and 240 days of support. The Silver package ($375) covers copyediting, artwork, journal selection, formatting, submission and revised-manuscript submission with 180 days of support.
The Platinum package includes support until your manuscript is accepted — we continue working with you through every revision round and, if needed, identify and prepare for a new target journal. Gold and Silver packages include fixed support windows (240 and 180 days respectively). No service can guarantee the editorial decision of an independent journal, but we guarantee our continued support throughout the process.
Under the Platinum package, rejection does not end our support. We analyse the rejection feedback, identify the correct re-submission route and prepare your manuscript for the next target journal. Our standalone Rejection Analysis & Recovery service ($200) also provides this structured diagnosis and re-route plan independently of any package.
Yes — reviewer-response support is included in the Gold and Platinum packages, and the preparation of a point-by-point response letter is a standalone service available separately. Our specialists address each reviewer comment substantively, clarifying the science without weakening your argument.
Yes. Every engagement is covered by a signed NDA. Editverse (Neucite LLC) never discloses your name, institution, manuscript content or any identifying information to journals, third parties or other clients. Unpublished data and manuscripts are handled in strict confidence and never repurposed.
We support submissions to SCI/SCIE (Web of Science), Scopus, PubMed/MEDLINE and DOAJ-indexed journals published by Elsevier, Springer, Wiley, Nature, PLOS, MDPI, BMC, Frontiers, Taylor & Francis, Oxford University Press, Cambridge University Press, IEEE and others. Every journal recommendation is screened for current indexing status and for predatory-publishing signals before we suggest it.
Yes — this is one of the most common reasons researchers engage us. We regularly work with authors from South Korea, China, Japan, Saudi Arabia, Egypt, Iran, Brazil, Germany, Spain and many other countries where English is not the primary academic language. Our editing goes beyond grammar to ensure the paper reads naturally and convincingly for an English-speaking editor.
Yes. Editverse (Neucite LLC) operates in full compliance with COPE (Committee on Publication Ethics) and ICMJE (International Committee of Medical Journal Editors) guidelines. This means authorship is always attributed correctly to you, reviewer suggestions follow COPE standards, AI assistance is disclosed transparently, and we never ghost-author or misrepresent the origin of any work.
Request a Free Quote
Tell us what you need. We reply within 24 hours — no obligation, pay only when satisfied.